Search results
Carpenter Technology (CRS) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 3 days agoBottom Line Given these factors, it shouldn't be surprising thatCRS is a #1 (Strong Buy) stock and...
Air Products (APD) AP-DMR LNG Process Passes Performance Test
Zacks via Yahoo Finance· 4 hours agoCarpenter Technology currently carries a Zacks Rank #1. CRS beat the Zacks Consensus Estimate in...
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 8 hours agoTurning to the summary of two responses as summarized on Slide 7 and among the 45 patients with baseline target lesion measurements in the 2 mg per kg...
The Zacks Rank Explained: How to Find Strong Buy Basic Materials Stocks
Zacks via Yahoo Finance· 2 days agoCRS also boasts an average earnings surprise of 15.1%. Analysts are expecting earnings to grow 266.7...
SpaceX launch recap: Starlink mission lifts off Monday before Starliner scrub at Cape Canaveral
Florida Today via Yahoo News· 4 days agoLive updates from Monday afternoon’s SpaceX Starlink 6-57 mission that launched a Falcon 9 rocket...
Earnings call: ADC Therapeutics sees revenue rise, advances ZYNLONTA trials By Investing.com
Investing.com· 4 days agoADC Therapeutics (NYSE: ADCT) has released its financial results for the first quarter of 2024,...
New Strong Buy Stocks for May 7th
Zacks via Yahoo Finance· 3 days agoQuote Carpenter Technology CRS: This company which is a producer and distributor of premium specialty alloys, including titanium alloys, powder metals,...
DOW to Sell Flexible Packaging Laminating Adhesives Business
Zacks· 2 days agoFree Report) recently stated that it has agreed to sell its flexible packaging laminating adhesives business, which is part of Dow's Packaging & Specialty Plastics unit, to Arkema, a specialty ...
Keeping an Eye on Carpenter Technology Corp.
Knox Daily· 2 days agoLevels Of Support And Resistance For CRS Stock The 24-hour chart illustrates a support level at 100.72, which if violated will result in even more drops to 98.91. On...stands ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
Tri-County Times· 7 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of investigational TAR-200 monotherapy in patients with BCG-unresponsive ...
